Recursion Pharmaceuticals, Inc. (RXRX)
3.245
-0.26
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
+0.02
(+0.46%)
After-Hours: 20:00
Recursion Pharmaceuticals Shareholders Equity (Quarterly) : 915.00M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 915.00M |
| March 31, 2026 | 1.025B |
| December 31, 2025 | 1.131B |
| September 30, 2025 | 1.047B |
| June 30, 2025 | 919.15M |
| March 31, 2025 | 933.95M |
| December 31, 2024 | 1.035B |
| September 30, 2024 | 524.56M |
| June 30, 2024 | 584.45M |
| March 31, 2024 | 401.15M |
| December 31, 2023 | 463.44M |
| September 30, 2023 | 437.97M |
| Date | Value |
|---|---|
| June 30, 2023 | 468.96M |
| March 31, 2023 | 430.18M |
| December 31, 2022 | 485.81M |
| September 30, 2022 | 388.03M |
| June 30, 2022 | 437.58M |
| March 31, 2022 | 493.57M |
| December 31, 2021 | 542.94M |
| September 30, 2021 | 599.03M |
| June 30, 2021 | 642.71M |
| March 31, 2021 | 215.28M |
| December 31, 2020 | 242.02M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Absci Corp. | 246.13M |
| Novavax, Inc. | -190.71M |
| Editas Medicine, Inc. | 105.28M |
| Dyne Therapeutics, Inc. | 702.15M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.213B |
| Total Liabilities (Quarterly) | 297.66M |
| Debt to Equity Ratio | 0.0728 |
| Current Ratio | 5.034 |
| Net Debt Paydown Yield | 0.27% |